Download Files:

Nullscript

$158

Only 1000 item(s) left in stock.

Products Details

Product Description

– Nullscript is a negative control for Scriptaid. Nullscript is a known inactive analog of Scriptaid[1]. Scriptaid is a representative HDAC inhibitor[2]. Nullscript inhibits Cryptosporidium (C. parvum) growth with the IC50 value of 2.1 μM[3].

Web ID

– HY-118421

Shipping

– Room temperature

Applications

– COVID-19-anti-virus

Molecular Formula

– C16H14N2O4

References

– [1]Fumi Murakoshi, et al. Nullscript inhibits <i>Cryptosporidium</i> and <i>Toxoplasma</i> growth. Int J Parasitol Drugs Drug Resist. 2020 Dec;14:159-166.|[2]Judith Clancy Keen, et al. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine. Breast Cancer Res Treat. 2003 |[3]Min Tong, et al. Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells. Biochem Pharmacol. 2006 Sep 14;72(6):701-9.

CAS Number

– 300816-11-9

Molecular Weight

– 298.29

SMILES

– O=C(N(C1=O)CCCC(NO)=O)C2=CC=CC3=CC=CC1=C23

Clinical Information

– No Development Reported

Research Area

– Infection

Solubility

– 10 mM in DMSO

Target

– HDAC;Parasite

Pathway

– Anti-infection;Cell Cycle/DNA Damage;Epigenetics

Product type

– Reference compound

Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.